$0.3191
0.00090.28%
At close: May 6, 5:00 PM EST
$0.3250
0.00682.14%
Pre-Market: 7:00 AM EST
IGC Pharma Inc Earnings Estimates
IGCAMEX
IGC Pharma Earnings Estimates, EPS & Revenue | AMEX:IGC
In the most recent quarter (Q3), IGC Pharma reported EPS of $-0.01, beating estimates of $-0.02 by 0.50%. Revenue came in at $213.00K, missing the estimate of $392.10K by 0.46%.
Over the last 4 quarters, IGC Pharma has averaged an EPS surprise of 0.33% and a revenue surprise of 0.25%.
Earnings Date
Mar 19
EPS
$-0.010
Quarterly Revenue
$213.00K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.20M
IGC Pharma Earnings History
Analyze the earnings history of IGC Pharma using advanced sorting and filters.
Loading calendar...
IGC Pharma (IGC) Earnings Per Share
The chart below shows IGC Pharma's reported EPS compared to analyst estimates over recent quarters.
IGC Pharma (IGC) Revenue
The chart below shows IGC Pharma's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is IGC Pharma (AMEX:IGC) reporting earnings?
IGC Pharma (IGC) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 19, 2026 for Q3.
What were the latest earnings per share (EPS) for IGC Pharma (AMEX:IGC)?
IGC Pharma (IGC) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 19, 2026 for Q3 and the Actual EPS was $-0.01, which beat the estimate of $-0.02.
What were IGC Pharma’s (AMEX:IGC) revenues?
IGC Pharma (IGC) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 19, 2026 for Q3 and the Actual Revenue was $213.00K, which missed the estimate of $392.10K.
